Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Overseed logo — Medical cannabis: from seed to purified pharmaceutical grade...

Overseed

Medical cannabis: from seed to purified pharmaceutical grade active ingredients

Founded 2021 France France 23 employees Series A Total: $9.20M Biopharma, Biotechnology

General Information

Company Name Overseed
Founded Year 2021
Location France France
Employees 23
Industries Biopharma, Biotechnology
Funding Stage Series A
Business Model B2B, B2D
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with Overseed. To contact Overseed, visit overseed.fr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Overseed compare?

A PDF of Overseed and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Overseed soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Overseed

Overseed, a pioneering French biotech enterprise, is forging a unique path in the field of medical cannabis. Founded in 2021, it distinguishes itself as the first company in France to receive an ANSM license for cannabis R&D directed towards pharmaceutical applications. With a slogan that emphasizes its commitment to delivering "Medical cannabis: from seed to purified pharmaceutical grade active ingredients," Overseed combines expertise across genetics, agronomy, organic chemistry, and pharmaceutical production.

The company aims to produce GACP and GMP certified cannabis products, including dried flowers, full spectrum extracts, and purified active ingredients, ensuring robust supply chain sovereignty and product quality.

In July 2024, Overseed secured a strategic €6.70M Series A investment, with backing from UI Investissement and Blast.club. This reflects strong investor confidence in its potential to meet patient and industry demands for quality and locally integrated production solutions.

Business keywords: Biotech, Cannabis R&D, Pharmaceutical Cannabis, GACP Certification, GMP Certification, Cannabinoids Development, Therapeutic Cannabis, Genetics, Agronomy, Organic Chemistry, Pharmaceutical Grade Ingredients, Full Spectrum Extracts, Medical Applications, Extraction Processes, Active Ingredients Purification

Services & Products

R&D on Cannabis Cultivation
Production of Pharmaceutical-grade Cannabinoids
Development of Cannabis-derived Products

Target Customers

Pharmaceutical Laboratories Medical Researchers Healthcare Industry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €6.70M 2
UI Investissement
UI Investissement, Blast.club
03 Jul 2024
Seed Round €2.50M -
30 Nov 2021

Overseed Alternatives & Competitors

View All Alternatives
Overseed vs
Celadon Pharmaceuticals
Celadon Pharmaceuticals United Kingdom

UK-based pharmaceutical company focused on R&D, cultivation, production and sale of cannabis-based m...

IPO
18 employees
Biopharma, Biotechnology
Overseed vs
士泽生物医药
士泽生物医药 China

病人第一 ，刀锋第二 ，股东第三

Series A
3 employees
Biopharma, Biotechnology
Overseed vs
Accutar Biotech
Accutar Biotech United States

Employ AI to Revolutionize Drug Discovery

Venture round
40 employees
AI, Biopharma
View all alternatives

FAQ About Overseed

Medical cannabis: from seed to purified pharmaceutical grade active ingredients
Overseed was founded in 2021.
Overseed is headquartered in France.
Overseed operates in Biopharma and Biotechnology. Its work centres on Biotech, Cannabis R&D, Pharmaceutical Cannabis and GACP Certification. Its customers include Pharmaceutical Laboratories, Medical Researchers and Healthcare Industry.
Overseed has a B2B and B2D business model. Its revenue comes from Product Sales, Service Fee and Licensing.
Overseed has approximately 23 employees.
Overseed has completed 2 funding rounds, raising a total of $9.20M. The latest funding stage is Series A.
Overseed offers: R&D on Cannabis Cultivation, Production of Pharmaceutical-grade Cannabinoids, Development of Cannabis-derived Products.
Top alternatives and competitors to Overseed include Celadon Pharmaceuticals, 士泽生物医药, Accutar Biotech, Poseida Therapeutics, Inc., Cellcolabs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Overseed and Celadon Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Overseed, https://bouncewatch.com/company/overseed, updated 28 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes